المؤلفون: Kong D.C.M., Thom O., Lawton L., Furyk J., Finucci D., Holdgate A., Watkins G., Jordan P., Keijzers G., Graudins A., Yap C.Y.L., Taylor D.M., Taylor S.E., Knott J.C., Kulawickrama S.

مصطلحات الفهرس: urine retention/si [Side Effect], urosepsis, vomiting/si [Side Effect], xerostomia/si [Side Effect], clonazepam/cb [Drug Combination], clonazepam/dt [Drug Therapy], clonazepam/im [Intramuscular Drug Administration], clonazepam/iv [Intravenous Drug Administration], diazepam/cb [Drug Combination], diazepam/dt [Drug Therapy], diazepam/im [Intramuscular Drug Administration], diazepam/iv [Intravenous Drug Administration], droperidol/cb [Drug Combination], droperidol/dt [Drug Therapy], droperidol/im [Intramuscular Drug Administration], droperidol/iv [Intravenous Drug Administration], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], haloperidol/im [Intramuscular Drug Administration], haloperidol/iv [Intravenous Drug Administration], ketamine/cb [Drug Combination], ketamine/dt [Drug Therapy], ketamine/im [Intramuscular Drug Administration], ketamine/iv [Intravenous Drug Administration], lorazepam/cb [Drug Combination], lorazepam/dt [Drug Therapy], lorazepam/im [Intramuscular Drug Administration], lorazepam/iv [Intravenous Drug Administration], midazolam/cb [Drug Combination], midazolam/dt [Drug Therapy], midazolam/im [Intramuscular Drug Administration], midazolam/iv [Intravenous Drug Administration], morphine/cb [Drug Combination], morphine/dt [Drug Therapy], morphine/im [Intramuscular Drug Administration], morphine/iv [Intravenous Drug Administration], olanzapine/dt [Drug Therapy], olanzapine/im [Intramuscular Drug Administration], olanzapine/iv [Intravenous Drug Administration], propofol/dt [Drug Therapy], propofol/im [Intramuscular Drug Administration], propofol/iv [Intravenous Drug Administration], sedative agent/ae [Adverse Drug Reaction], sedative agent/dt [Drug Therapy], olanzapine/cb [Drug Combination], monotherapy, observational study, oxygen desaturation, prescription, prospective study, psychiatric emergency, QT prolongation/si [Side Effect], sedation, adult, aged, airway obstruction/si [Side Effect], alcohol intoxication, anaphylaxis/si [Side Effect], article, Australia, behavior disorder/dt [Drug Therapy], bradycardia/si [Side Effect], clinical outcome, dementia, extrapyramidal symptom/si [Side Effect], female, human, hypotension/si [Side Effect], hypoventilation/si [Side Effect], major clinical study, male, tachycardia/si [Side Effect], Article

URL: Journal of Pharmacy Practice and Research
Click here for full text options
LibKey Link

المؤلفون: Kong D.C.M., Thom O., Lawton L., Furyk J., Finucci D., Holdgate A., Watkins G., Jordan P., Keijzers G., Graudins A., Yap C.Y.L., Taylor D.M., Taylor S.E., Knott J.C., Kulawickrama S.

مصطلحات الفهرس: urine retention/si [Side Effect], urosepsis, vomiting/si [Side Effect], xerostomia/si [Side Effect], clonazepam/cb [Drug Combination], clonazepam/dt [Drug Therapy], clonazepam/im [Intramuscular Drug Administration], clonazepam/iv [Intravenous Drug Administration], diazepam/cb [Drug Combination], diazepam/dt [Drug Therapy], diazepam/im [Intramuscular Drug Administration], diazepam/iv [Intravenous Drug Administration], droperidol/cb [Drug Combination], droperidol/dt [Drug Therapy], droperidol/im [Intramuscular Drug Administration], droperidol/iv [Intravenous Drug Administration], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], haloperidol/im [Intramuscular Drug Administration], haloperidol/iv [Intravenous Drug Administration], ketamine/cb [Drug Combination], ketamine/dt [Drug Therapy], ketamine/im [Intramuscular Drug Administration], ketamine/iv [Intravenous Drug Administration], lorazepam/cb [Drug Combination], lorazepam/dt [Drug Therapy], lorazepam/im [Intramuscular Drug Administration], lorazepam/iv [Intravenous Drug Administration], midazolam/cb [Drug Combination], midazolam/dt [Drug Therapy], midazolam/im [Intramuscular Drug Administration], midazolam/iv [Intravenous Drug Administration], morphine/cb [Drug Combination], morphine/dt [Drug Therapy], morphine/im [Intramuscular Drug Administration], morphine/iv [Intravenous Drug Administration], olanzapine/dt [Drug Therapy], olanzapine/im [Intramuscular Drug Administration], olanzapine/iv [Intravenous Drug Administration], propofol/dt [Drug Therapy], propofol/im [Intramuscular Drug Administration], propofol/iv [Intravenous Drug Administration], sedative agent/ae [Adverse Drug Reaction], sedative agent/dt [Drug Therapy], olanzapine/cb [Drug Combination], monotherapy, observational study, oxygen desaturation, prescription, prospective study, psychiatric emergency, QT prolongation/si [Side Effect], sedation, adult, aged, airway obstruction/si [Side Effect], alcohol intoxication, anaphylaxis/si [Side Effect], article, Australia, behavior disorder/dt [Drug Therapy], bradycardia/si [Side Effect], clinical outcome, dementia, extrapyramidal symptom/si [Side Effect], female, human, hypotension/si [Side Effect], hypoventilation/si [Side Effect], major clinical study, male, tachycardia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36048
Journal of Pharmacy Practice and Research
LibKey Link

المؤلفون: Kanellis J., Mulley W., Summers S., Dave V.

مصطلحات الفهرس: bipolar disorder/dt [Drug Therapy], case report, creatinine blood level, drug dose increase, drug withdrawal, end stage renal disease/co [Complication], end stage renal disease/th [Therapy], evening dosage, female, graft failure/co [Complication], graft recipient, graft rejection/co [Complication], graft rejection/dt [Drug Therapy], grandiose delusion, human, immunosuppressive treatment, kidney biopsy, kidney graft, kidney transplantation, low drug dose, maintenance therapy, mental health, middle aged, morning dosage, nephrotoxicity, plasmapheresis, postoperative complication/co [Complication], practice guideline, priority journal, psychosis/si [Side Effect], review, alemtuzumab/dt [Drug Therapy], basiliximab/dt [Drug Therapy], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], HLA antigen, immunoglobulin/iv [Intravenous Drug Administration], immunosuppressive agent, methylprednisolone/dt [Drug Therapy], methylprednisolone/iv [Intravenous Drug Administration], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisolone/pa [Parenteral Drug Administration], rapamycin, tacrolimus/ae [Adverse Drug Reaction], kidney function, benzatropine/cb [Drug Combination], benzatropine/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/dt [Drug Therapy], clonazepam/cb [Drug Combination], clonazepam/dt [Drug Therapy], creatinine/ec [Endogenous Compound], cyclosporin/dt [Drug Therapy], cytochrome P450, everolimus/dt [Drug Therapy], everolimus/pa [Parenteral Drug Administration], acute psychosis, adult, antibody mediated rejection, auditory hallucination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40796
Nephrology
Click here for full text options
LibKey Link

المؤلفون: Kanellis J., Mulley W., Summers S., Dave V.

مصطلحات الفهرس: bipolar disorder/dt [Drug Therapy], case report, creatinine blood level, drug dose increase, drug withdrawal, end stage renal disease/co [Complication], end stage renal disease/th [Therapy], evening dosage, female, graft failure/co [Complication], graft recipient, graft rejection/co [Complication], graft rejection/dt [Drug Therapy], grandiose delusion, human, immunosuppressive treatment, kidney biopsy, kidney graft, kidney transplantation, low drug dose, maintenance therapy, mental health, middle aged, morning dosage, nephrotoxicity, plasmapheresis, postoperative complication/co [Complication], practice guideline, priority journal, psychosis/si [Side Effect], review, alemtuzumab/dt [Drug Therapy], basiliximab/dt [Drug Therapy], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], HLA antigen, immunoglobulin/iv [Intravenous Drug Administration], immunosuppressive agent, methylprednisolone/dt [Drug Therapy], methylprednisolone/iv [Intravenous Drug Administration], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisolone/pa [Parenteral Drug Administration], rapamycin, tacrolimus/ae [Adverse Drug Reaction], kidney function, benzatropine/cb [Drug Combination], benzatropine/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/dt [Drug Therapy], clonazepam/cb [Drug Combination], clonazepam/dt [Drug Therapy], creatinine/ec [Endogenous Compound], cyclosporin/dt [Drug Therapy], cytochrome P450, everolimus/dt [Drug Therapy], everolimus/pa [Parenteral Drug Administration], acute psychosis, adult, antibody mediated rejection, auditory hallucination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40796
Nephrology
LibKey Link

المؤلفون: Franco M., Koulaeva E.

مصطلحات الفهرس: case report, defecation, dehydration, digestive tract endoscopy, duodenum, duodenum stent, endoscopic retrograde cholangiopancreatography, esophagography, gastroenterology, gastroscopy, human, intestine sound, kidney dysfunction, lethargy, male, nasogastric tube, nausea and vomiting/co [Complication], nausea and vomiting/dt [Drug Therapy], nausea and vomiting/th [Therapy], palliative therapy, pancreas carcinoma, paraneoplastic gastroparesis/dt [Drug Therapy], paraneoplastic syndrome/di [Diagnosis], paraneoplastic syndrome/dt [Drug Therapy], residential care, stomach distension, stomach emptying, stomach motility, stomach paresis/di [Diagnosis], stomach paresis/dt [Drug Therapy], weight reduction, contrast medium, article, domperidone/dt [Drug Therapy], domperidone/po [Oral Drug Administration], erythromycin/dt [Drug Therapy], erythromycin/iv [Intravenous Drug Administration], erythromycin/po [Oral Drug Administration], haloperidol/dt [Drug Therapy], haloperidol/sc [Subcutaneous Drug Administration], metoclopramide/dt [Drug Therapy], metoclopramide/po [Oral Drug Administration], paraneoplastic gastroparesis/di [Diagnosis], abdominal pain, aged, biliary stent, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41775
Palliative Medicine
Click here for full text options
LibKey Link

المؤلفون: Franco M., Koulaeva E.

مصطلحات الفهرس: case report, defecation, dehydration, digestive tract endoscopy, duodenum, duodenum stent, endoscopic retrograde cholangiopancreatography, esophagography, gastroenterology, gastroscopy, human, intestine sound, kidney dysfunction, lethargy, male, nasogastric tube, nausea and vomiting/co [Complication], nausea and vomiting/dt [Drug Therapy], nausea and vomiting/th [Therapy], palliative therapy, pancreas carcinoma, paraneoplastic gastroparesis/dt [Drug Therapy], paraneoplastic syndrome/di [Diagnosis], paraneoplastic syndrome/dt [Drug Therapy], residential care, stomach distension, stomach emptying, stomach motility, stomach paresis/di [Diagnosis], stomach paresis/dt [Drug Therapy], weight reduction, contrast medium, article, domperidone/dt [Drug Therapy], domperidone/po [Oral Drug Administration], erythromycin/dt [Drug Therapy], erythromycin/iv [Intravenous Drug Administration], erythromycin/po [Oral Drug Administration], haloperidol/dt [Drug Therapy], haloperidol/sc [Subcutaneous Drug Administration], metoclopramide/dt [Drug Therapy], metoclopramide/po [Oral Drug Administration], paraneoplastic gastroparesis/di [Diagnosis], abdominal pain, aged, biliary stent, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41775
Palliative Medicine
Click here for full text options
LibKey Link

المؤلفون: Mewett G., Kenner D., Brumley D., Ashby M., Kerr D., Viney M., Jackson K., Franco M., William L., Poon P., Pisasale M.

مصطلحات الفهرس: drug mechanism, human, letter, low drug dose, neurologic disease/dt [Drug Therapy], neurologic disease/pc [Prevention], neurologic disease/si [Side Effect], priority journal, treatment outcome, analgesic agent/dt [Drug Therapy], haloperidol/dt [Drug Therapy], ketamine/ae [Adverse Drug Reaction], ketamine/dt [Drug Therapy], ketamine/sc [Subcutaneous Drug Administration], midazolam/dt [Drug Therapy], opiate/dt [Drug Therapy], drug safety, analgesic activity, cancer pain/dt [Drug Therapy], clinical protocol, drug efficacy, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27682
Click here for full text options
LibKey Link

المؤلفون: Mewett G., Kenner D., Brumley D., Ashby M., Kerr D., Viney M., Jackson K., Franco M., William L., Poon P., Pisasale M.

مصطلحات الفهرس: drug mechanism, human, letter, low drug dose, neurologic disease/dt [Drug Therapy], neurologic disease/pc [Prevention], neurologic disease/si [Side Effect], priority journal, treatment outcome, analgesic agent/dt [Drug Therapy], haloperidol/dt [Drug Therapy], ketamine/ae [Adverse Drug Reaction], ketamine/dt [Drug Therapy], ketamine/sc [Subcutaneous Drug Administration], midazolam/dt [Drug Therapy], opiate/dt [Drug Therapy], drug safety, analgesic activity, cancer pain/dt [Drug Therapy], clinical protocol, drug efficacy, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27682
LibKey Link

المؤلفون: Bruera E., Hui D., Bush S.H., Gallo L.E., Palmer J.L., Yennurajalingam S.

مصطلحات الفهرس: haloperidol/pa [Parenteral Drug Administration], add on therapy, adult, advanced cancer, aged, agitation, article, cancer patient, caregiver, correlation analysis, correlational study, delirium/dt [Drug Therapy], delirium/th [Therapy], distress syndrome, drug efficacy, drug use, female, health care personnel, human, job stress, major clinical study, male, medical record, medical specialist, nurse, palliative therapy, retrospective study, statistical significance, symptom, chlorpromazine/dt [Drug Therapy], chlorpromazine/pa [Parenteral Drug Administration], haloperidol/dt [Drug Therapy], haloperidol/iv [Intravenous Drug Administration], haloperidol/po [Oral Drug Administration], lorazepam/dt [Drug Therapy], midazolam/dt [Drug Therapy], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], olanzapine/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31044
Click here for full text options
LibKey Link

المؤلفون: Copolov D., Kulkarni J., De Castella A., Smith D., Taffe J., Keks N.

مصطلحات الفهرس: clinical article, clinical trial, controlled clinical trial, controlled study, female, human, schizophrenia/dt [Drug Therapy], benzodiazepine/dt [Drug Therapy], chlorpromazine/dt [Drug Therapy], estradiol/ct [Clinical Trial], estradiol/dt [Drug Therapy], estrogen/ct [Clinical Trial], estrogen/dt [Drug Therapy], haloperidol/dt [Drug Therapy], neuroleptic agent/dt [Drug Therapy], thioridazine/dt [Drug Therapy], trifluoperazine/dt [Drug Therapy], priority journal, adult, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33981
Click here for full text options
LibKey Link

المؤلفون: Willis G.L., Armstrong S.M.

مصطلحات الفهرس: mental disease/et [Etiology], mesencephalon, nerve cell degeneration, neuroaxonal dystrophy/et [Etiology], neurologic disease/et [Etiology], neuropathology, neurotoxicity/et [Etiology], neurotoxicity/si [Side Effect], nonhuman, Parkinson disease/dt [Drug Therapy], Parkinson disease/et [Etiology], Parkinson disease/su [Surgery], Parkinson disease/th [Therapy], priority journal, review, schizophrenia/et [Etiology], substantia nigra, 1,2,3,6 tetrahydro 1 methyl 4 phenylpyridine, 2 chloro 11 (3 dimethylaminopropylidene)morphanthridine/dt [Drug Therapy], 2 chloro 11 (3 dimethylaminopropylidene)morphanthridine/pd [Pharmacology], alpha tocopherol/pd [Pharmacology], amine/to [Drug Toxicity], antioxidant/pd [Pharmacology], clozapine/dt [Drug Therapy], clozapine/pd [Pharmacology], domperidone/pd [Pharmacology], dopamine, dopamine receptor blocking agent/ae [Adverse Drug Reaction], dopamine receptor blocking agent/cb [Drug Combination], dopamine receptor blocking agent/dt [Drug Therapy], dopamine receptor blocking agent/pd [Pharmacology], dopamine receptor stimulating agent/ae [Adverse Drug Reaction], dopamine receptor stimulating agent/dt [Drug Therapy], dopamine receptor stimulating agent/pd [Pharmacology], flumezapine/dt [Drug Therapy], flumezapine/pd [Pharmacology], fluperlapine/dt [Drug Therapy], fluperlapine/pd [Pharmacology], haloperidol/dt [Drug Therapy], haloperidol/pd [Pharmacology], hormone receptor blocking agent/pd [Pharmacology], levodopa/dt [Drug Therapy], levodopa/pd [Pharmacology], melatonin receptor/pd [Pharmacology], metirosine/pd [Pharmacology], monoamine oxidase inhibitor/pd [Pharmacology], neuroleptic agent/dt [Drug Therapy], neuroleptic agent/pd [Pharmacology], pentiapine maleate/dt [Drug Therapy], pentiapine maleate/pd [Pharmacology], rimcazole/dt [Drug Therapy], rimcazole/pd [Pharmacology], risperidone/pd [Pharmacology], unclassified drug, c 177328, motor dysfunction/si [Side Effect], catecholamine synthesis, akathisia/et [Etiology], brain protection, catecholamine release, diencephalon, dopaminergic system, drug efficacy, drug mechanism, Gilles de la Tourette syndrome/et [Etiology], human, Huntington chorea/et [Etiology], hypothalamus, implant, Lewy body/et [Etiology], Review

URL: Click here for full text options
LibKey Link

المؤلفون: Burger H., Kulkarni J., De Castella A., Fitzgerald P.B., Gurvich C.T., Bailey M., Bartholomeusz C.

مصطلحات الفهرس: article, clinical trial, controlled clinical trial, controlled study, disease severity, double blind procedure, drug efficacy, drug withdrawal, female, general hospital, hospital patient, human, major clinical study, outcome assessment, outpatient, Positive and Negative Syndrome Scale, randomized controlled trial, schizoaffective psychosis/dt [Drug Therapy], schizophreniform disorder/dt [Drug Therapy], statistical significance, symptom, treatment outcome, ward, chlorpromazine/cb [Drug Combination], chlorpromazine/dt [Drug Therapy], clozapine/cb [Drug Combination], clozapine/dt [Drug Therapy], estradiol/ct [Clinical Trial], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/td [Transdermal Drug Administration], flupentixol/cb [Drug Combination], flupentixol/dt [Drug Therapy], fluphenazine/dt [Drug Therapy], fluphenazine decanoate/cb [Drug Combination], fluphenazine decanoate/dt [Drug Therapy], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], olanzapine/cb [Drug Combination], olanzapine/dt [Drug Therapy], placebo, quetiapine/cb [Drug Combination], quetiapine/dt [Drug Therapy], risperidone/cb [Drug Combination], risperidone/dt [Drug Therapy], trifluoperazine/dt [Drug Therapy], zuclopenthixol/cb [Drug Combination], zuclopenthixol/dt [Drug Therapy], schizophrenia/dt [Drug Therapy], acute psychosis/dt [Drug Therapy], adult, Article

URL: Click here for full text options
LibKey Link

المؤلفون: Pavey G., Copolov D.L., Dean B., Hussain T., Scarr E.

مصطلحات الفهرس: drug effect, drug receptor binding, ligand binding, male, nonhuman, psychosis/dt [Drug Therapy], rat, receptor density, 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 4 aminobutyric acid A receptor/ec [Endogenous Compound], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate, chlorpromazine/cm [Drug Comparison], chlorpromazine/do [Drug Dose], chlorpromazine/dt [Drug Therapy], chlorpromazine/po [Oral Drug Administration], chlorpromazine/pd [Pharmacology], clozapine/cm [Drug Comparison], clozapine/do [Drug Dose], clozapine/dt [Drug Therapy], clozapine/po [Oral Drug Administration], clozapine/pd [Pharmacology], dopamine 2 receptor/ec [Endogenous Compound], emonapride, haloperidol/cm [Drug Comparison], haloperidol/do [Drug Dose], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], muscimol, olanzapine/pd [Pharmacology], radioligand, tritium, haloperidol/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], neuroleptic agent/po [Oral Drug Administration], neuroleptic agent/pd [Pharmacology], olanzapine/cm [Drug Comparison], olanzapine/do [Drug Dose], olanzapine/dt [Drug Therapy], animal experiment, animal model, animal tissue, article, brain nerve cell, controlled study, corpus striatum, dose time effect relation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33203
Click here for full text options
LibKey Link

المؤلفون: Greve M., O'Connor D.

مصطلحات الفهرس: somnolence/si [Side Effect], treatment indication, antidepressant agent/cm [Drug Comparison], antidepressant agent/dt [Drug Therapy], atypical antipsychotic agent/ae [Adverse Drug Reaction], atypical antipsychotic agent/ct [Clinical Trial], atypical antipsychotic agent/dt [Drug Therapy], benzodiazepine derivative/cm [Drug Comparison], benzodiazepine derivative/dt [Drug Therapy], buspirone/dt [Drug Therapy], carbamazepine/dt [Drug Therapy], cholinesterase inhibitor/dt [Drug Therapy], diazepam/dt [Drug Therapy], haloperidol/cm [Drug Comparison], haloperidol/dt [Drug Therapy], mood stabilizer/dt [Drug Therapy], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/dt [Drug Therapy], olanzapine/ae [Adverse Drug Reaction], olanzapine/ct [Clinical Trial], olanzapine/dt [Drug Therapy], oxazepam/cm [Drug Comparison], oxazepam/dt [Drug Therapy], risperidone/ae [Adverse Drug Reaction], risperidone/ct [Clinical Trial], risperidone/dt [Drug Therapy], serotonin uptake inhibitor/dt [Drug Therapy], sex hormone/dt [Drug Therapy], thioridazine/dt [Drug Therapy], trazodone/cm [Drug Comparison], trazodone/dt [Drug Therapy], tricyclic antidepressant agent/dt [Drug Therapy], valproic acid/dt [Drug Therapy], human, aggression, Australia, behavior disorder/dt [Drug Therapy], clinical trial, dementia/dt [Drug Therapy], disease association, drug potency, gait disorder/si [Side Effect], medical practice, New Zealand, prescription, psychiatrist, psychosis/dt [Drug Therapy], review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32251
Click here for full text options
LibKey Link

المؤلفون: Bruera E., Hui D., Bush S.H., Gallo L.E., Palmer J.L., Yennurajalingam S.

مصطلحات الفهرس: haloperidol/pa [Parenteral Drug Administration], add on therapy, adult, advanced cancer, aged, agitation, article, cancer patient, caregiver, correlation analysis, correlational study, delirium/dt [Drug Therapy], delirium/th [Therapy], distress syndrome, drug efficacy, drug use, female, health care personnel, human, job stress, major clinical study, male, medical record, medical specialist, nurse, palliative therapy, retrospective study, statistical significance, symptom, chlorpromazine/dt [Drug Therapy], chlorpromazine/pa [Parenteral Drug Administration], haloperidol/dt [Drug Therapy], haloperidol/iv [Intravenous Drug Administration], haloperidol/po [Oral Drug Administration], lorazepam/dt [Drug Therapy], midazolam/dt [Drug Therapy], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], olanzapine/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31044
LibKey Link

المؤلفون: Copolov D., Kulkarni J., De Castella A., Smith D., Taffe J., Keks N.

مصطلحات الفهرس: clinical article, clinical trial, controlled clinical trial, controlled study, female, human, schizophrenia/dt [Drug Therapy], benzodiazepine/dt [Drug Therapy], chlorpromazine/dt [Drug Therapy], estradiol/ct [Clinical Trial], estradiol/dt [Drug Therapy], estrogen/ct [Clinical Trial], estrogen/dt [Drug Therapy], haloperidol/dt [Drug Therapy], neuroleptic agent/dt [Drug Therapy], thioridazine/dt [Drug Therapy], trifluoperazine/dt [Drug Therapy], priority journal, adult, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33981
LibKey Link

المؤلفون: Armatas C.A., Churchyard A., Fitzgerald P.B., Georgiou-Karistianis N., Hoy K.E., Bradshaw J.L., Farrow M., Chiu E.

مصطلحات الفهرس: antidepressant agent/dt [Drug Therapy], benserazide/dt [Drug Therapy], bromide/dt [Drug Therapy], citalopram/dt [Drug Therapy], fumaric acid/dt [Drug Therapy], haloperidol/dt [Drug Therapy], moclobemide/dt [Drug Therapy], neuroleptic agent/dt [Drug Therapy], olanzapine/dt [Drug Therapy], quetiapine/dt [Drug Therapy], propranolol/dt [Drug Therapy], valproic acid/dt [Drug Therapy], tetrabenazine/dt [Drug Therapy], sertraline/dt [Drug Therapy], article, clinical article, controlled study, correlation analysis, disease severity, hand, human, Huntington chorea/dt [Drug Therapy], hypothesis, measurement, motor performance, priority journal, statistical significance, strength, task performance, voluntary movement, anticonvulsive agent/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32595
LibKey Link

المؤلفون: Willis G.L., Armstrong S.M.

مصطلحات الفهرس: mental disease/et [Etiology], mesencephalon, nerve cell degeneration, neuroaxonal dystrophy/et [Etiology], neurologic disease/et [Etiology], neuropathology, neurotoxicity/et [Etiology], neurotoxicity/si [Side Effect], nonhuman, Parkinson disease/dt [Drug Therapy], Parkinson disease/et [Etiology], Parkinson disease/su [Surgery], Parkinson disease/th [Therapy], priority journal, review, schizophrenia/et [Etiology], substantia nigra, 1,2,3,6 tetrahydro 1 methyl 4 phenylpyridine, 2 chloro 11 (3 dimethylaminopropylidene)morphanthridine/dt [Drug Therapy], 2 chloro 11 (3 dimethylaminopropylidene)morphanthridine/pd [Pharmacology], alpha tocopherol/pd [Pharmacology], amine/to [Drug Toxicity], antioxidant/pd [Pharmacology], clozapine/dt [Drug Therapy], clozapine/pd [Pharmacology], domperidone/pd [Pharmacology], dopamine, dopamine receptor blocking agent/ae [Adverse Drug Reaction], dopamine receptor blocking agent/cb [Drug Combination], dopamine receptor blocking agent/dt [Drug Therapy], dopamine receptor blocking agent/pd [Pharmacology], dopamine receptor stimulating agent/ae [Adverse Drug Reaction], dopamine receptor stimulating agent/dt [Drug Therapy], dopamine receptor stimulating agent/pd [Pharmacology], flumezapine/dt [Drug Therapy], flumezapine/pd [Pharmacology], fluperlapine/dt [Drug Therapy], fluperlapine/pd [Pharmacology], haloperidol/dt [Drug Therapy], haloperidol/pd [Pharmacology], hormone receptor blocking agent/pd [Pharmacology], levodopa/dt [Drug Therapy], levodopa/pd [Pharmacology], melatonin receptor/pd [Pharmacology], metirosine/pd [Pharmacology], monoamine oxidase inhibitor/pd [Pharmacology], neuroleptic agent/dt [Drug Therapy], neuroleptic agent/pd [Pharmacology], pentiapine maleate/dt [Drug Therapy], pentiapine maleate/pd [Pharmacology], rimcazole/dt [Drug Therapy], rimcazole/pd [Pharmacology], risperidone/pd [Pharmacology], unclassified drug, c 177328, motor dysfunction/si [Side Effect], catecholamine synthesis, akathisia/et [Etiology], brain protection, catecholamine release, diencephalon, dopaminergic system, drug efficacy, drug mechanism, Gilles de la Tourette syndrome/et [Etiology], human, Huntington chorea/et [Etiology], hypothalamus, implant, Lewy body/et [Etiology], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33759
LibKey Link

المؤلفون: Burger H., Kulkarni J., De Castella A., Fitzgerald P.B., Gurvich C.T., Bailey M., Bartholomeusz C.

مصطلحات الفهرس: article, clinical trial, controlled clinical trial, controlled study, disease severity, double blind procedure, drug efficacy, drug withdrawal, female, general hospital, hospital patient, human, major clinical study, outcome assessment, outpatient, Positive and Negative Syndrome Scale, randomized controlled trial, schizoaffective psychosis/dt [Drug Therapy], schizophreniform disorder/dt [Drug Therapy], statistical significance, symptom, treatment outcome, ward, chlorpromazine/cb [Drug Combination], chlorpromazine/dt [Drug Therapy], clozapine/cb [Drug Combination], clozapine/dt [Drug Therapy], estradiol/ct [Clinical Trial], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/td [Transdermal Drug Administration], flupentixol/cb [Drug Combination], flupentixol/dt [Drug Therapy], fluphenazine/dt [Drug Therapy], fluphenazine decanoate/cb [Drug Combination], fluphenazine decanoate/dt [Drug Therapy], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], olanzapine/cb [Drug Combination], olanzapine/dt [Drug Therapy], placebo, quetiapine/cb [Drug Combination], quetiapine/dt [Drug Therapy], risperidone/cb [Drug Combination], risperidone/dt [Drug Therapy], trifluoperazine/dt [Drug Therapy], zuclopenthixol/cb [Drug Combination], zuclopenthixol/dt [Drug Therapy], schizophrenia/dt [Drug Therapy], acute psychosis/dt [Drug Therapy], adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31680
LibKey Link

المؤلفون: Greve M., O'Connor D.

مصطلحات الفهرس: somnolence/si [Side Effect], treatment indication, antidepressant agent/cm [Drug Comparison], antidepressant agent/dt [Drug Therapy], atypical antipsychotic agent/ae [Adverse Drug Reaction], atypical antipsychotic agent/ct [Clinical Trial], atypical antipsychotic agent/dt [Drug Therapy], benzodiazepine derivative/cm [Drug Comparison], benzodiazepine derivative/dt [Drug Therapy], buspirone/dt [Drug Therapy], carbamazepine/dt [Drug Therapy], cholinesterase inhibitor/dt [Drug Therapy], diazepam/dt [Drug Therapy], haloperidol/cm [Drug Comparison], haloperidol/dt [Drug Therapy], mood stabilizer/dt [Drug Therapy], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/dt [Drug Therapy], olanzapine/ae [Adverse Drug Reaction], olanzapine/ct [Clinical Trial], olanzapine/dt [Drug Therapy], oxazepam/cm [Drug Comparison], oxazepam/dt [Drug Therapy], risperidone/ae [Adverse Drug Reaction], risperidone/ct [Clinical Trial], risperidone/dt [Drug Therapy], serotonin uptake inhibitor/dt [Drug Therapy], sex hormone/dt [Drug Therapy], thioridazine/dt [Drug Therapy], trazodone/cm [Drug Comparison], trazodone/dt [Drug Therapy], tricyclic antidepressant agent/dt [Drug Therapy], valproic acid/dt [Drug Therapy], human, aggression, Australia, behavior disorder/dt [Drug Therapy], clinical trial, dementia/dt [Drug Therapy], disease association, drug potency, gait disorder/si [Side Effect], medical practice, New Zealand, prescription, psychiatrist, psychosis/dt [Drug Therapy], review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32251
LibKey Link